Detalhe da pesquisa
1.
Flu Shows the Power of Diversity.
Cell
; 176(1-2): 9-10, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30633911
2.
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.
Immunity
; 56(11): 2621-2634.e6, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967533
3.
Cryptic proteins translated from deletion-containing viral genomes dramatically expand the influenza virus proteome.
Nucleic Acids Res
; 52(6): 3199-3212, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407436
4.
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
J Virol
; 98(1): e0161823, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174928
5.
Virology-the path forward.
J Virol
; 98(1): e0179123, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168672
6.
When influenza viruses don't play well with others.
Nature
; 616(7958): 668-669, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019958
7.
Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction.
J Infect Dis
; 227(8): 981-992, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468309
8.
Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.
J Virol
; 96(10): e0020522, 2022 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467364
9.
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
J Virol
; 95(24): e0117421, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550771
10.
Cellular co-infection can modulate the efficiency of influenza A virus production and shape the interferon response.
PLoS Pathog
; 16(10): e1008974, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064776
11.
Single cell heterogeneity in influenza A virus gene expression shapes the innate antiviral response to infection.
PLoS Pathog
; 16(7): e1008671, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614923
12.
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection.
J Infect Dis
; 224(6): 976-982, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34191025
13.
Sequencing Framework for the Sensitive Detection and Precise Mapping of Defective Interfering Particle-Associated Deletions across Influenza A and B Viruses.
J Virol
; 93(11)2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867305
14.
Correction for Rasmussen et al., "Virology-the path forward".
J Virol
; 98(3): e0007424, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334328
15.
Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
PLoS Pathog
; 14(6): e1007141, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924863
16.
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
PLoS Pathog
; 14(1): e1006796, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346435
17.
Population Diversity and Collective Interactions during Influenza Virus Infection.
J Virol
; 91(22)2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28855247
18.
Influenza virus DI particles: Defective interfering or delightfully interesting?
PLoS Pathog
; 16(5): e1008436, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437428
19.
Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility.
Proc Natl Acad Sci U S A
; 111(47): 16854-9, 2014 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25385602
20.
Response to Bender et al.
J Infect Dis
; 224(11): 1989, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648633